跳至主要内容
临床试验/NCT04515537
NCT04515537招募中不适用

The Effect of Cyanophyta Aphanizomenon Flos-aquae (Stemregen), and Adipose Stroma Vascular Fraction (SVF) Either Individual or in Combination in Patient With Heart Failure

Sociedad Española de Medicina Regenerativa y Terapia Celular1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2021年5月20日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
15
试验地点
1
主要终点
Change of echocardiographic Parameters [ Time Frame: 0 and 6 months ]

研究概览

简要总结

This study is a prospective, randomized, controlled trial to assess the efficacy of transplantation of autologous stroma vauscultar fraction and/or AFA in 15 patients with ischemic heart failure

详细描述

Stem cells therapy may be a choice therapy for advanced heart failure patients refractory to medical therapy, and a previous history of coronary artery diseases. In this study the investigators have evaluated consecutive 15 selected patients, the amelioration in failing heart NYHA class, hospitalization rate, echocardiographic left ventricle functionality, serum of Natriuretic peptide level and associated to reduction of angina after a treatment with stroma vascular fraction infusion y/or Stemregen capsule per oral.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
35 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • EF < 45 %
  • NYHA 2 - 3

排除标准

  • Acute coronary syndrome within last 6 weeks.
  • Pregnancy
  • FEV1 <20 %
  • Any severe disease which could interfere with the treatment or the outcome
  • Patient with immunodeficiency
  • Candidate who are judged to be not applicable to this study by doctors.

结局指标

主要结局

Change of echocardiographic Parameters [ Time Frame: 0 and 6 months ]

时间窗: 6 months

Left Ventricular end-systolic volume index (LVESVI) Left Ventricular end-systolic dimension Left Ventricular end-diastolic volume Left Ventricular end-diastolic dimension. \[ Time Frame: 6 months from trial admission\]

Change NYHA functional class assessed with SAQ-7 -questionnaire

时间窗: 6 month

The improvement in patient's quality of life after 6 months of trial admission. The quality of life will be determined with Seattle Angina Questionnaire 7 (SAQ-7). Each domain has a score calculated on a scale of 0 (= worst health quality) to 100 (= best health quality)

次要结局

  • Change NYHA functional class assessed with SAQ-7 -questionnaire(12 months)
  • Change of echocardiographic Parameters [ Time Frame: 0 and 12 months ](12 months)

研究者

发起方
Sociedad Española de Medicina Regenerativa y Terapia Celular
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验